Essner, Ute
O. Meany Consultancy GmbH, Hamburg, Germany;
2 papers on CoChatORCID 0000-0003-4502-0948
Most cited papers
- Verified
Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Markovà, J., Essner, U., Akmaz, B., Marinelli, M., Trompke, C., Lentschat, A., & Vila, C. (2019) · International Journal of Neuroscience
Botulinum Toxin and Related Neurological DisordersCannabis and Cannabinoid Research
Cited by 151
- Verified
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
Akgün, K., Essner, U., Seydel, C., & Ziemssen, T. (2019) · Journal of Central Nervous System Disease
Cannabis and Cannabinoid ResearchBotulinum Toxin and Related Neurological Disorders
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free